Article Text

other Versions

PDF
Neurodegenerative disorders and metabolic disease
  1. Germaine Pierre
  1. Correspondence to Dr Germaine Pierre, Division of Women's and Children's Services, Bristol Royal Hospital for Children, Level 6, UHBT, Education Centre, Upper Maudlin Street, Bristol BS2 8AE, UK; germaine.pierre{at}uhbristol.nhs.uk

Abstract

Most genetic causes of neurodegenerative disorders in childhood are due to neurometabolic disease. There are over 200 disorders, including aminoacidopathies, creatine disorders, mitochondrial cytopathies, peroxisomal disorders and lysosomal storage disorders. However, diagnosis can pose a challenge to the clinician when patients present with non-specific problems like epilepsy, developmental delay, autism, dystonia and ataxia. The variety of specialist tests involved can also be daunting. This review aims to give a practical approach to the investigation and diagnosis of neurometabolic disease from the neonatal period to late childhood while prioritising disorders where there are therapeutic options. In particular, patients who have a complex clinical picture of several neurological and non-neurological features should be investigated.

  • neurodegenerative
  • neurometabolic
  • developmental delay
  • Metabolic
  • encephalopathy

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Atoms
    R Mark Beattie